(Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (FY)Dec 31, 2019 | |
---|---|---|---|---|---|---|---|---|---|
Turnover | -11.12%5.59B | 0.69%11.39B | 6.42%6.29B | 9.94%11.31B | 7.05%5.91B | 16.22%10.29B | --5.53B | -1.36%8.85B | --8.98B |
Operating income | -11.12%5.59B | 0.69%11.39B | 6.42%6.29B | 9.94%11.31B | 7.05%5.91B | 16.22%10.29B | 5.53B | -1.36%8.85B | 8.98B |
Cost of sales | 10.86%-4.98B | -0.78%-10.08B | -6.58%-5.58B | -9.47%-10B | -6.36%-5.24B | -13.51%-9.13B | ---4.92B | 0.66%-8.05B | ---8.1B |
Operating expenses | 10.86%-4.98B | -0.78%-10.08B | -6.58%-5.58B | -9.47%-10B | -6.36%-5.24B | -13.51%-9.13B | -4.92B | 0.66%-8.05B | -8.1B |
Gross profit | -13.20%618.51M | 0.04%1.31B | 5.19%712.53M | 13.65%1.31B | 12.66%677.39M | 43.22%1.16B | 601.25M | -7.87%807.43M | 876.36M |
Selling expenses | -22.57%-296.62M | 3.36%-481.99M | 1.70%-242M | -10.41%-498.76M | -11.62%-246.18M | -14.48%-451.73M | ---220.56M | -14.42%-394.59M | ---344.86M |
Administrative expenses | -14.86%-168.7M | 2.50%-313.53M | 6.57%-146.87M | -4.73%-321.58M | -0.55%-157.21M | -42.43%-307.07M | ---156.35M | 8.98%-215.59M | ---236.87M |
Research and development expenses | 10.50%-66.32M | 15.84%-145.59M | 14.11%-74.11M | -23.79%-172.98M | -32.29%-86.28M | -31.77%-139.74M | ---65.22M | -78.99%-106.05M | ---59.25M |
Impairment and provision | 36.28%-8.88M | -981.18%-23.55M | -1,949.20%-13.94M | 59.44%-2.18M | 106.40%754K | 74.30%-5.37M | ---11.78M | -89.09%-20.89M | ---11.05M |
-Other impairment is provision | 36.28%-8.88M | -981.18%-23.55M | -1,949.20%-13.94M | 59.44%-2.18M | 106.40%754K | 74.30%-5.37M | ---11.78M | -89.09%-20.89M | ---11.05M |
Special items of operating profit | 5.53%49.93M | 0.35%66.44M | 27.18%47.31M | 55.37%66.21M | 43.47%37.2M | -44.94%42.61M | --25.93M | -17.25%77.4M | --93.53M |
Operating profit | -54.79%127.92M | 8.21%416.61M | 25.37%282.93M | 30.44%385M | 30.25%225.68M | 99.83%295.14M | 173.26M | -53.53%147.7M | 317.85M |
Financing income | 35.85%27.89M | 28.74%40.9M | 33.11%20.53M | 31.88%31.77M | 200.23%15.42M | 97.60%24.09M | --5.14M | 302.24%12.19M | --3.03M |
Financing cost | -36.69%-52.53M | 9.48%-75.8M | 11.65%-38.43M | -7.10%-83.74M | -28.77%-43.5M | -50.18%-78.19M | ---33.78M | -16.55%-52.07M | ---44.67M |
Share of profits of associates | -153.85%-4.01M | -105.08%-677K | -21.07%7.45M | -19.12%13.33M | -0.96%9.44M | 268.83%16.48M | --9.54M | -29.67%-9.76M | ---7.53M |
Special items of earning before tax | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---26.35M | ---- |
Earning before tax | -63.57%99.26M | 10.01%381.03M | 31.60%272.48M | 34.50%346.36M | 34.31%207.05M | 259.12%257.53M | 154.16M | -73.31%71.71M | 268.68M |
Tax | 30.20%-15.31M | -2.03%-41.04M | -2.01%-21.93M | -11.23%-40.23M | -5.57%-21.5M | -38.81%-36.16M | ---20.36M | -27.81%-26.05M | ---20.38M |
After-tax profit from continuing operations | -66.49%83.96M | 11.06%339.99M | 35.03%250.55M | 38.30%306.14M | 38.68%185.55M | 384.83%221.36M | 133.79M | -81.61%45.66M | 248.3M |
Earning after tax | -66.49%83.96M | 11.06%339.99M | 35.03%250.55M | 38.30%306.14M | 38.68%185.55M | 384.83%221.36M | 133.79M | -81.61%45.66M | 248.3M |
Minority profit | 55.63%-4.55M | -26.60%-21.73M | -15.23%-10.26M | -91.05%-17.16M | -64.36%-8.9M | -163.79%-8.98M | ---5.42M | -194.55%-3.41M | ---1.16M |
Profit attributable to shareholders | -66.06%88.51M | 11.88%361.72M | 34.12%260.81M | 40.35%323.3M | 39.68%194.45M | 369.49%230.35M | 139.21M | -80.33%49.06M | 249.45M |
Basic earnings per share | -64.69%0.0583 | 6.59%0.2297 | 27.39%0.1651 | 40.30%0.2155 | 39.66%0.1296 | 369.72%0.1536 | 0.0928 | -80.34%0.0327 | 0.1663 |
Diluted earnings per share | -64.69%0.0583 | 6.59%0.2297 | 27.39%0.1651 | 40.30%0.2155 | 39.66%0.1296 | 369.72%0.1536 | 0.0928 | -80.34%0.0327 | 0.1663 |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | Unqualified Opinion |
Auditor | -- | Xinyong Zhonghe Certified Public Accountants (Special General Partnership) Shenzhen Branch | -- | Xinyong Zhonghe Certified Public Accountants (Special General Partnership) Shenzhen Branch | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | PricewaterhouseCoopers |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data
No Data